Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study

Third-generation chimeric antigen receptor T cells (CARTs) for relapsed or refractory (r/r) chronic lymphocytic leukemia (CLL) may improve efficacy compared to second-generation CARTs due to their enhanced CAR design. We performed the first phase 1/2 investigator-initiated trial evaluating escalatin...

Full description

Saved in:
Bibliographic Details
Main Authors: Derigs, Patrick (Author) , Schubert, Maria-Luisa (Author) , Dreger, Peter (Author) , Schmitt, Anita (Author) , Yousefian, Schayan (Author) , Haas, Simon (Author) , Röthemeier, Caroline (Author) , Neuber, Brigitte (Author) , Hückelhoven-Krauss, Angela (Author) , Brüggemann, Monika (Author) , Bernhard, Helga (Author) , Kobbe, Guido (Author) , Lindemann, Albrecht (Author) , Rummel, Mathias (Author) , Michels, Birgit (Author) , Korell, Felix (Author) , Ho, Anthony Dick (Author) , Müller-Tidow, Carsten (Author) , Schmitt, Michael (Author)
Format: Article (Journal)
Language:English
Published: 27 August 2024
In: Leukemia
Year: 2024, Volume: 38, Issue: 11, Pages: 2419-2428
ISSN:1476-5551
DOI:10.1038/s41375-024-02392-7
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-024-02392-7
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-024-02392-7
Get full text
Author Notes:Patrick Derigs, Maria-Luisa Schubert, Peter Dreger, Anita Schmitt, Schayan Yousefian, Simon Haas, Caroline Röthemeier, Brigitte Neuber, Angela Hückelhoven-Krauss, Monika Brüggemann, Helga Bernhard, Guido Kobbe, Albrecht Lindemann, Mathias Rummel, Birgit Michels, Felix Korell, Anthony D. Ho, Carsten Müller-Tidow and Michael Schmitt

MARC

LEADER 00000naa a2200000 c 4500
001 1935348787
003 DE-627
005 20250905120449.0
007 cr uuu---uuuuu
008 250905s2024 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41375-024-02392-7  |2 doi 
035 |a (DE-627)1935348787 
035 |a (DE-599)KXP1935348787 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Derigs, Patrick  |d 1991-  |e VerfasserIn  |0 (DE-588)1178057461  |0 (DE-627)1049128508  |0 (DE-576)517664216  |4 aut 
245 1 0 |a Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia  |b a phase 1/2 study  |c Patrick Derigs, Maria-Luisa Schubert, Peter Dreger, Anita Schmitt, Schayan Yousefian, Simon Haas, Caroline Röthemeier, Brigitte Neuber, Angela Hückelhoven-Krauss, Monika Brüggemann, Helga Bernhard, Guido Kobbe, Albrecht Lindemann, Mathias Rummel, Birgit Michels, Felix Korell, Anthony D. Ho, Carsten Müller-Tidow and Michael Schmitt 
246 3 0 |a nineteen 
264 1 |c 27 August 2024 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.09.2025 
520 |a Third-generation chimeric antigen receptor T cells (CARTs) for relapsed or refractory (r/r) chronic lymphocytic leukemia (CLL) may improve efficacy compared to second-generation CARTs due to their enhanced CAR design. We performed the first phase 1/2 investigator-initiated trial evaluating escalating doses of third-generation CARTs (HD-CAR-1) targeting CD19 in patients with r/r CLL and B-cell lymphoma. CLL eligibility criteria were failure to two therapy lines including at least one pathway inhibitor and/or allogeneic hematopoietic cell transplantation. Nine heavily pretreated patients received HD-CAR-1 at dose levels ranging from 1 × 106 to 200 × 106 CART/m2. In-house HD-CAR-1 manufacturing was successful for all patients. While neurotoxicity was absent, one case of grade 3 cytokine release syndrome was observed. By day 90, six patients (67%) attained a CR, five of these (83%) with undetectable MRD. With a median follow-up of 27 months, 2-year PFS and OS were 30% and 69%, respectively. HD-CAR-1 products of responders contained significantly more CD4 + T cells compared to non-responders. In non-responders, a strong enrichment of effector memory-like CD8 + T cells with high expression of CD39 and/or CD197 was observed. HD-CAR-1 demonstrated encouraging efficacy and exceptionally low treatment-specific toxicity, presenting new treatment options for patients with r/r CLL. Trial registration: #NCT03676504. 
650 4 |a Chronic lymphocytic leukaemia 
650 4 |a Immunotherapy 
650 4 |a Phase I trials 
650 4 |a Phase II trials 
650 4 |a Translational research 
700 1 |a Schubert, Maria-Luisa  |d 1982-  |e VerfasserIn  |0 (DE-588)1147867631  |0 (DE-627)1007273801  |0 (DE-576)49608089X  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Schmitt, Anita  |d 1969-  |e VerfasserIn  |0 (DE-588)141722495  |0 (DE-627)630587752  |0 (DE-576)325593892  |4 aut 
700 1 |a Yousefian, Schayan  |e VerfasserIn  |4 aut 
700 1 |a Haas, Simon  |e VerfasserIn  |4 aut 
700 1 |a Röthemeier, Caroline  |e VerfasserIn  |4 aut 
700 1 |a Neuber, Brigitte  |d 1974-  |e VerfasserIn  |0 (DE-588)1052913563  |0 (DE-627)789293188  |0 (DE-576)408653884  |4 aut 
700 1 |a Hückelhoven-Krauss, Angela  |d 1983-  |e VerfasserIn  |0 (DE-588)1034095889  |0 (DE-627)744057280  |0 (DE-576)381742822  |4 aut 
700 1 |a Brüggemann, Monika  |e VerfasserIn  |4 aut 
700 1 |a Bernhard, Helga  |e VerfasserIn  |4 aut 
700 1 |a Kobbe, Guido  |e VerfasserIn  |4 aut 
700 1 |a Lindemann, Albrecht  |e VerfasserIn  |4 aut 
700 1 |a Rummel, Mathias  |e VerfasserIn  |4 aut 
700 1 |a Michels, Birgit  |e VerfasserIn  |4 aut 
700 1 |a Korell, Felix  |e VerfasserIn  |0 (DE-588)1214671659  |0 (DE-627)1725690284  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 38(2024), 11, Seite 2419-2428  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia a phase 1/2 study 
773 1 8 |g volume:38  |g year:2024  |g number:11  |g pages:2419-2428  |g extent:10  |a Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia a phase 1/2 study 
856 4 0 |u https://doi.org/10.1038/s41375-024-02392-7  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41375-024-02392-7  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250905 
993 |a Article 
994 |a 2024 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 19  |y j 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 18 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 17 
998 |g 1214671659  |a Korell, Felix  |m 1214671659:Korell, Felix  |d 910000  |d 910100  |e 910000PK1214671659  |e 910100PK1214671659  |k 0/910000/  |k 1/910000/910100/  |p 16 
998 |g 1034095889  |a Hückelhoven-Krauss, Angela  |m 1034095889:Hückelhoven-Krauss, Angela  |d 910000  |d 910100  |e 910000PH1034095889  |e 910100PH1034095889  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 1052913563  |a Neuber, Brigitte  |m 1052913563:Neuber, Brigitte  |d 910000  |d 910100  |e 910000PN1052913563  |e 910100PN1052913563  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 141722495  |a Schmitt, Anita  |m 141722495:Schmitt, Anita  |d 910000  |d 910100  |d 50000  |e 910000PS141722495  |e 910100PS141722495  |e 50000PS141722495  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 4 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1147867631  |a Schubert, Maria-Luisa  |m 1147867631:Schubert, Maria-Luisa  |d 910000  |d 910100  |e 910000PS1147867631  |e 910100PS1147867631  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1178057461  |a Derigs, Patrick  |m 1178057461:Derigs, Patrick  |d 910000  |d 910100  |e 910000PD1178057461  |e 910100PD1178057461  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1935348787  |e 4768924468 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"title":[{"title":"Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia","subtitle":"a phase 1/2 study","title_sort":"Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia"}],"person":[{"given":"Patrick","roleDisplay":"VerfasserIn","family":"Derigs","role":"aut","display":"Derigs, Patrick"},{"roleDisplay":"VerfasserIn","given":"Maria-Luisa","family":"Schubert","role":"aut","display":"Schubert, Maria-Luisa"},{"family":"Dreger","given":"Peter","roleDisplay":"VerfasserIn","display":"Dreger, Peter","role":"aut"},{"family":"Schmitt","roleDisplay":"VerfasserIn","given":"Anita","display":"Schmitt, Anita","role":"aut"},{"role":"aut","display":"Yousefian, Schayan","given":"Schayan","roleDisplay":"VerfasserIn","family":"Yousefian"},{"family":"Haas","roleDisplay":"VerfasserIn","given":"Simon","display":"Haas, Simon","role":"aut"},{"family":"Röthemeier","given":"Caroline","roleDisplay":"VerfasserIn","display":"Röthemeier, Caroline","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Brigitte","family":"Neuber","role":"aut","display":"Neuber, Brigitte"},{"role":"aut","display":"Hückelhoven-Krauss, Angela","given":"Angela","roleDisplay":"VerfasserIn","family":"Hückelhoven-Krauss"},{"display":"Brüggemann, Monika","role":"aut","family":"Brüggemann","roleDisplay":"VerfasserIn","given":"Monika"},{"family":"Bernhard","roleDisplay":"VerfasserIn","given":"Helga","display":"Bernhard, Helga","role":"aut"},{"family":"Kobbe","roleDisplay":"VerfasserIn","given":"Guido","display":"Kobbe, Guido","role":"aut"},{"role":"aut","display":"Lindemann, Albrecht","roleDisplay":"VerfasserIn","given":"Albrecht","family":"Lindemann"},{"family":"Rummel","given":"Mathias","roleDisplay":"VerfasserIn","display":"Rummel, Mathias","role":"aut"},{"display":"Michels, Birgit","role":"aut","family":"Michels","roleDisplay":"VerfasserIn","given":"Birgit"},{"role":"aut","display":"Korell, Felix","roleDisplay":"VerfasserIn","given":"Felix","family":"Korell"},{"family":"Ho","given":"Anthony Dick","roleDisplay":"VerfasserIn","display":"Ho, Anthony Dick","role":"aut"},{"role":"aut","display":"Müller-Tidow, Carsten","given":"Carsten","roleDisplay":"VerfasserIn","family":"Müller-Tidow"},{"display":"Schmitt, Michael","role":"aut","family":"Schmitt","roleDisplay":"VerfasserIn","given":"Michael"}],"name":{"displayForm":["Patrick Derigs, Maria-Luisa Schubert, Peter Dreger, Anita Schmitt, Schayan Yousefian, Simon Haas, Caroline Röthemeier, Brigitte Neuber, Angela Hückelhoven-Krauss, Monika Brüggemann, Helga Bernhard, Guido Kobbe, Albrecht Lindemann, Mathias Rummel, Birgit Michels, Felix Korell, Anthony D. Ho, Carsten Müller-Tidow and Michael Schmitt"]},"relHost":[{"origin":[{"publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedKey":"1997"}],"disp":"Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia a phase 1/2 studyLeukemia","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"32046699X","note":["Gesehen am 15.03.04"],"pubHistory":["Nachgewiesen 11.1997 -"],"language":["eng"],"id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"part":{"text":"38(2024), 11, Seite 2419-2428","volume":"38","issue":"11","year":"2024","extent":"10","pages":"2419-2428"},"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"eki":["1935348787"],"doi":["10.1038/s41375-024-02392-7"]},"language":["eng"],"note":["Gesehen am 05.09.2025"],"recId":"1935348787","type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"27 August 2024"}]} 
SRT |a DERIGSPATRTHIRDGENER2720